Principia Biopharma (PRNB) PT Lowered to $62 at H.C. Wainwright, Maintains 'Buy'
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Principia Biopharma (NASDAQ: PRNB) to $62.00 (from $63.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
